Evidence map›Paper›PMID 42432787›Full record

ArticleEpigenetics & chromatin2026

Human Alu loci gain enhancer-type epigenetic modifications in monocytes during response to bacterial LPS.

Yonghao Pan, Kenji Ichiyanagi

Abstract read
In one paragraph

Article in Epigenetics & chromatin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yonghao PanLaboratory of Genome and Epigenome Dynamics, Department of Animal Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa- ku, Nagoya, 464-8601, Japan. pan.yonghao.x7@s.mail.nagoya-u.ac.jp.
Kenji IchiyanagiLaboratory of Genome and Epigenome Dynamics, Department of Animal Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa- ku, Nagoya, 464-8601, Japan. ichiyana@agr.nagoya-u.ac.jp.

Funding

Grant-in-Aid for Challenging Exploratory Research 23K18153Grant-in-Aid for Transformative Research Areas 25H01299)Make New Standards Program at Nagoya University 0125z62002
6 · The paper itself

Abstract

backgroundBacterial lipopolysaccharide (LPS) potently activates innate immunity. Transposable elements (TEs), particularly lineage-specific short interspersed elements (SINEs), have been implicated in immune regulatory evolution, yet their epigenomic roles during immune activation remain unclear.

resultsHere, we reanalyzed published ChIP-seq data for H3K4me1, H3K4me3, and H3K27ac from human monocytes and mouse macrophage-like cells under basal and LPS-stimulated conditions. We identified widespread and dynamic activation of Alu-associated regulatory regions in human monocytes, accounting for around 15% of total enhancer-associated ChIP-seq peaks with and without LPS stimulation. In particular, over one quarter of the Alu-containing H3K4me1 and H3K27ac peaks appeared only after LPS stimulation. The Alu-containing enhancers that appeared in short treatment with LPS linked to many genes involved in the acute immune and inflammatory responses. On the other hand, prolonged LPS stimulation produced stronger chromatin activation at Alu loci that were linked to genes with more dispersed pathway associations, likely reflecting post-stimulation adaptation or tolerance.

conclusionsThese findings suggest that Alu elements act as regulatory scaffolds that shape the temporal and functional landscape of human immune responses. Our findings suggest that Alu elements, as primate-specific TEs, may contribute to heightened sensitivity to LPS by shaping species-specific enhancer landscapes.

Indexed as

Alu ElementsEnhancer Elements, GeneticEpigenesis, GeneticLipopolysaccharidesMonocytesAnimalsHistonesHumansMiceHistonesLipopolysaccharidesAlu elementEnhancer regulationEpigenomicsInnate immunity

Identifiers

PMID42432787
PMCPMC13584426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.